Dekabank Deutsche Girozentrale / PFE
Dekabank Deutsche Girozentrale’s Pfizer Inc Position
Does Dekabank Deutsche Girozentrale own Pfizer Inc (PFE)? Yes — 7.40M shares worth $211M (+0.35% of its 13F portfolio) as of Q1 2026.
Position Value
$211M
Q1 2026
Shares
7.40M
% of Portfolio
+0.35%
Quarters Held
28
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.40M | $211M | +0.35% |
| Q4 2025 | 7.40M | $208M | +0.36% |
| Q3 2025 | 7.40M | $176M | +0.30% |
| Q2 2025 | 7.40M | $180M | +0.32% |
| Q1 2025 | 7.38M | $183M | +0.36% |
| Q4 2024 | 7.40M | $196M | +0.36% |
| Q3 2024 | 7.40M | $215M | +0.40% |
| Q2 2024 | 7.31M | $205M | +0.37% |
| Q1 2024 | 7.38M | $205M | +0.38% |
| Q4 2023 | 8.16M | $235M | +0.48% |
| Q3 2023 | 7.75M | $250M | +0.58% |
| Q2 2023 | 8.32M | $303M | +0.68% |
| Q1 2023 | 7.86M | $317M | +0.80% |
| Q4 2022 | 7.73M | $396M | +1.05% |
| Q3 2022 | 8.19M | $362M | +1.07% |
| Q2 2022 | 8.35M | $425M | +1.24% |
| Q1 2022 | 8.20M | $431M | +1.05% |
| Q4 2021 | 6.94M | $402M | +0.98% |
| Q3 2021 | 5.75M | $250M | +0.70% |
| Q2 2021 | 6.18M | $241M | +0.70% |
| Q1 2021 | 6.67M | $243M | +0.81% |
| Q3 2020 | 6.65M | $241M | +1.07% |
| Q2 2020 | 5.83M | $192M | +1.21% |
| Q1 2020 | 6.68M | $217M | +1.66% |
| Q4 2019 | 7.02M | $276M | +1.69% |
| Q3 2019 | 7.17M | $260M | +1.61% |
| Q2 2019 | 8.14M | $354M | +1.78% |
| Q1 2019 | 7.52M | $313M | +1.86% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of PFE.